Anaplastic Oligodendroglioma (AO) Completed Phase 2 Trials for Carmustine (DB00262)
Also known as: Anaplastic Oligodendroglioma / Anaplastic Oligodendrogliomas / Malignant oligodendroglioma / Oligodendroglioma, anaplastic (morphologic abnormality) / Oligodendroglioma malignant
Indication | Status | Phase |
---|---|---|
DBCOND0052374 (Anaplastic Oligodendroglioma (AO)) | Completed | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00004688 | Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms | Treatment |